David A. Siegel Jazz Pharmaceuticals PLC Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 21,700 shares of JAZZ stock, worth $2.28 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,700
Previous 5,500
294.55%
Holding current value
$2.28 Million
Previous $676,000
286.54%
% of portfolio
0.01%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding JAZZ
# of Institutions
513Shares Held
57MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$743 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$678 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$259 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$250 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$157 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.59B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...